Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology : A decision-curve analysis
Shahrokh F. Shariat, Caroline Savage, Thomas F. Chromecki, Maxine Sun, Douglas S. Scherr, Richard K. Lee, Giovanni Lughezzani, Mesut Remzi, Michael J. Marberger, Pierre I. Karakiewicz, Andrew J. VickeVolume:
117
Year:
2011
Language:
english
Pages:
6
DOI:
10.1002/cncr.25903
File:
PDF, 170 KB
english, 2011